Cargando…
High Expression Levels of AGGF1 and MFAP4 Predict Primary Platinum-Based Chemoresistance and are Associated with Adverse Prognosis in Patients with Serous Ovarian Cancer
Primary platinum-based chemoresistance occurs in approximately one-third of patients with serous ovarian cancer (SOC); however, traditional clinical indicators are poor predictors of chemoresistance. So we aimed to identify novel genes as predictors of primary platinum-based chemoresistance. Gene ex...
Autores principales: | Zhao, Haiyue, Sun, Qian, Li, Lisong, Zhou, Jinhua, Zhang, Cong, Hu, Ting, Zhou, Xuemei, Zhang, Long, Wang, Baiyu, Li, Bo, Zhu, Tao, Li, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360311/ https://www.ncbi.nlm.nih.gov/pubmed/30719133 http://dx.doi.org/10.7150/jca.28127 |
Ejemplares similares
-
Expression and Clinical Significance of the NCAPH, AGGF1, and FOXC2 Proteins in Serous Ovarian Cancer
por: Sun, Yingying, et al.
Publicado: (2021) -
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021) -
Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer
por: Zhang, Xin, et al.
Publicado: (2019) -
A Platinum Resistance-Related lncRNA Signature for Risk Classification and Prognosis Prediction in Patients with Serous Ovarian Cancer
por: Zhu, Yan, et al.
Publicado: (2022) -
MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway
por: Yao, Li-wen, et al.
Publicado: (2020)